Anti-HER2 therapy efficacy in HER2-negative metastatic breast cancer with HER2-amplified circulating tumor cells: results of the CirCe T-DM1 trial
Autor: | Véronique Diéras, L. Venat-Bouvet, E. Luporsi-Gely, Marc Espié, Séverine Guiu, F-C Bidard, Véronique D'Hondt, Marc A. Bollet, V. Servent Hanon, Coraline Dubot, J-Y Pierga, Alain Lortholary, Souhir Neffati, M.P. Sablin, H Bourgeois, William Jacot, PH Cottu, Frédérique Berger |
---|---|
Rok vydání: | 2017 |
Předmět: |
0301 basic medicine
CA15-3 Oncology medicine.medical_specialty business.industry HER2 negative Hematology medicine.disease Metastatic breast cancer 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Breast cancer Circulating tumor cell 030220 oncology & carcinogenesis Internal medicine medicine Therapy efficacy business |
Zdroj: | Annals of Oncology. 28:v32 |
ISSN: | 0923-7534 |
Databáze: | OpenAIRE |
Externí odkaz: |